Abstract
Maternal healthcare financing is key to the smooth functioning of maternal health systems in a country. In India, maternal healthcare persists as a significant public health issue. Adequate health insurance could transform the utilization of maternal health care services to prevent maternal consequences. This paper aims to examine the health insurance policies that cover maternal health and their performance in India. The unit-level social consumption data on health by the National Sample Survey Organizations (NSSO), conducted in India (2017-18), is used. Bi-variate analysis, logistic regression, and propensity scoring matching (PSM) are used to evaluate the coverage of health insurance coverage on women’s maternal health care utilization. Our findings suggest that spending on health insurance can benefit pregnant women, especially among the poor, without financial stress. The study has also minimized the financial burden and prevent high-risk pregnancy-related complications and consequences. Also, there is a need for proactive and inclusive policy development by the Government of India to promote more health insurance schemes in the public and private sectors. This can bring down the risk of maternal mortality and also boost the Indian economy in terms of a better quality of life in the long run, and the way towards more just and more egalitarian societies.
Highlights
Around 14.1% of Indian women are covered with health insurance schemes.
Muslim women have the lowest health insurance coverage in India.
Women covered with health insurance schemes has showed significant contributor to the better utilization of full ANC and institutional delivery compared to uncovered women in India.
A proactive and inclusive policy development is needed by the Government of India to promote more for health insurance schemes better quality of life in the long run.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not required
Funding Statement
None.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB and/or ethics committee approvals are not required for the present study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The present study has used the 75th round of National Sample Survey Organization (NSSO) data under the Ministry of Statistics and Program Implementation (MOSPI), conducted in India. The study has used unit data of social consumption on health, schedule 25.0 of the 75th round (2017-18) by the NSSO, Government of India (July 2017 to June 2018). This data is openly available for the study.
